fda shortage semaglutide injection resolved feb 21 2025 status january As of February 21, 2025, the updated its drug list fda declares semaglutide shortage resolved

Tesamorelin is still relevant, but it is not driving the same broad metabolic conversation

Weight loss being a reported side effect of Ozempic helped pave the way for other GLP-1 medications, like Wegovy , that are specifically FDA-approved for weight loss

Wegovy contains semaglutide

PlexusDx sources all compounded medications exclusively from licensed 503A compounding pharmacies, which operate under strict FDA oversight and state pharmacy board regulations

They should be comfortable with receiving/administering injections and committed to making the necessary lifestyle changes to promote and sustain their weight loss

R.GageF